Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

CRS-207

Name: Phase 1b trial of CRS-207 with chemotherapy for malignant pleural mesothelioma
Uploaded: 2016-04-15T00:00:00.000Z
Duration: 1 min 34 s
Description: At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, David Carbone, MD, PhD, from The Ohio State University Wexner Medical Center, Columbus, OH, discusses a phase 1b trial of the anti-mesothelin vaccine CRS-207 plus chemotherapy as frontline treatment for malignant pleural mesothelioma.

Sorry, no posts matched your criteria.

CRS-207

Cookie settings